organophosphonates has been researched along with Malaria in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arinaitwe, E; Charland, K; Dorsey, G; Greenhouse, B; Jahagirdar, D; Kamya, MR; Morrison, K; Nankabirwa, J; Rek, JC; Rodriguez-Barraquer, I; Sadoine, ML; Staedke, SG; Tutt-Guérette, MA; Vahey, S; Zinszer, K | 1 |
| Aratikatla, EK; Asad, M; Bhattacharya, AK; Datta, G; Kalamuddin, M; Malhotra, P; Mohmmed, A; Rana, KC; Sundararaman, S | 1 |
| Chavchich, M; Edstein, MD; Guddat, LW; Hocková, D; Janeba, Z; Keough, DT; Naesens, L | 1 |
| Aba, YT; Aoussi, EF; Bissagnene, E; Eholié, SP; Ehui, E; Kadio, A; Kakou, AR; Kassi, A; Ondounda, M; Ouattara, I; Tanon, A | 1 |
| Chipato, T; Cole, SR; Currier, JS; D'Amico, R; Eron, JJ; Hosseinipour, M; Hughes, MD; Lockman, S; McCarthy, JS; Meshnick, SR; Poole, C; Porter, KA; Salata, R; Sawe, FK; Shaffer, D; Siika, A; Skinner-Adams, TS; Stringer, E; Zheng, Y | 1 |
| de Jersey, J; Guddat, LW; Hocková, D; Janeba, Z; Keough, DT; Wang, TH | 1 |
| Amighi, K; Blankert, B; Kambu, O; Kauffmann, JM; Malongo, TK; Nsangu, J | 1 |
| Dorrestein, GM; Franssen, FF; Hermsen, RC; Nieuwenhuijs, H; Overdulve, JP; Smeijsters, LJ | 1 |
| Altincicek, B; Beck, E; Dreiseidler, E; Jomaa, H; Reichenberg, A; Sanderbrand, S; Schlitzer, M; Weidemeyer, C; Wiesner, J | 1 |
| Chavalitshewinkoon, P; de Clercq, E; de Vries, E; Franssen, FF; Nieuwenhuijs, H; Overdulve, JP; Stam, JG; van der Vliet, PC | 1 |
1 trial(s) available for organophosphonates and Malaria
| Article | Year |
|---|---|
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Lopinavir; Malaria; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome | 2012 |
9 other study(ies) available for organophosphonates and Malaria
| Article | Year |
|---|---|
The Impact of Multiple Rounds of Indoor Residual Spraying on Malaria Incidence and Hemoglobin Levels in a High-Transmission Setting.
Topics: Child; Child, Preschool; Cohort Studies; Female; Hemoglobins; Humans; Incidence; Infant; Insecticides; Malaria; Male; Mosquito Control; Organophosphonates; Parasitemia; Phenylcarbamates; Uganda | 2020 |
Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Topics: Antimalarials; Artemisinins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Heme; Malaria; Molecular Structure; Organophosphonates; Parasitic Sensitivity Tests; Peptides; Plasmodium falciparum; Polymerization; Structure-Activity Relationship; Vinyl Compounds | 2021 |
Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases.
Topics: Antimalarials; Enzyme Inhibitors; Humans; Hypoxanthine Phosphoribosyltransferase; Malaria; Models, Molecular; Nucleotides; Organophosphonates; Prodrugs | 2015 |
[Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast].
Topics: Adenine; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cote d'Ivoire; Cyclopropanes; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Fanconi Syndrome; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Malaria; Male; Middle Aged; Organophosphonates; Pyelonephritis; Pyrimidinones; Ritonavir; Tenofovir | 2011 |
Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.
Topics: Antimalarials; Drug Design; Enzyme Inhibitors; Humans; Hypoxanthine Phosphoribosyltransferase; Malaria; Models, Molecular; Molecular Conformation; Nucleosides; Organophosphonates; Pentosyltransferases; Plasmodium falciparum; Plasmodium vivax; Protein Binding; Substrate Specificity | 2012 |
Amodiaquine polymeric membrane electrode.
Topics: Adipates; Amodiaquine; Antimalarials; Chemistry, Pharmaceutical; Diethylhexyl Phthalate; Electrodes; Ethers; Ions; Malaria; Nitrobenzenes; Organophosphonates; Pharmaceutical Preparations; Polyvinyl Chloride; Sensitivity and Specificity; Tablets; Tetraphenylborate | 2006 |
Antimalarial and toxic effects of the acyclic nucleoside phosphonate (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine in Plasmodium berghei-infected mice.
Topics: Adenine; Animals; Antimalarials; Delayed-Action Preparations; Malaria; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Plasmodium berghei; Probenecid | 1996 |
Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Topics: Aldose-Ketose Isomerases; Animals; Antimalarials; Disease Models, Animal; Fosfomycin; Malaria; Mice; Multienzyme Complexes; Organophosphonates; Oxidoreductases; Plasmodium; Prodrugs; Treatment Outcome | 2001 |
Inhibition of the growth of Plasmodium falciparum and Plasmodium berghei by the DNA polymerase inhibitor HPMPA.
Topics: Adenine; Animals; Antiprotozoal Agents; Binding, Competitive; Cell Line; Deoxyadenine Nucleotides; Erythrocytes; Humans; Malaria; Mice; Mice, Inbred BALB C; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Plasmodium berghei; Plasmodium falciparum | 1991 |